Moreover, a 32-fold increased risk for MS was seen in people who seroconverted compared to those who remained EBV-negative and a good correlation with neurofilament light (NFL) serum levels, a marker for neurodegeneration was seen. Here, NEFL is linked to myeloid sarcoma.